Stock listing
Irlab Therapeutics Ab Class A
Selected listing: IRLAAS · AQUISUK · SEK · GB
Irlab Therapeutics Ab Class A (Aquis:IRLAAS), Health Technology. Latest release Sep 24, 2026: IRLAB Appoints Janne Backman as New Chairman of the Board.
- Ticker
- Aquis:IRLAAS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Aquis
- Currency
- SEK
Latest news from Irlab Therapeutics Ab Class A
IRLAB Appoints Janne Backman as New Chairman of the Board
September 24, 2026
Report from the Extraordinary General Meeting of IRLAB Therapeutics AB
June 5, 2026
IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process (ISP)
January 19, 2026
IRLAB Receives Approval for a Phase Ib Study with IRL757 in Parkinson's Disease
December 23, 2025
The European Patent Office Intends to Grant a New Patent for IRLAB's Mesdopetam
December 11, 2025
Events
Research Irlab Therapeutics Ab Class A
Irlab Therapeutics Ab Class A company profile
View the public company page for Irlab Therapeutics Ab Class A on 6ix.
Irlab Therapeutics Ab Class A news
Read company news and market updates connected to Irlab Therapeutics Ab Class A.
Irlab Therapeutics Ab Class A investor events
Find investor webinars, events, and replay context for Irlab Therapeutics Ab Class A.
Alternate listings
IRLABA:OMXSTO
SE · SEK
Alternate listing for Irlab Therapeutics Ab Class A; the primary context on this page is IRLAAS:AQUISUK.
IRLAAS:AQUISEU
GB · SEK
Alternate listing for Irlab Therapeutics Ab Class A; the primary context on this page is IRLAAS:AQUISUK.
6IRA:FWB
DE · EUR
Alternate listing for Irlab Therapeutics Ab Class A; the primary context on this page is IRLAAS:AQUISUK.